Search research articles
Contact Us
Filters
Showing results (181-190 of 190) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 190 results.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1989
Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomas
B Wiedenmann, P Reichardt, U Räth, et al.
Cancer
|
July 15, 1993
Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials
U Keilholz, C Scheibenbogen, W Tilgen, et al.
Leukemia Research
|
January 1, 1990
Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsiveness
C Weiss, A D Ho, E Hiller, et al.
Cancer
|
April 15, 1992
Regional administration of lymphokine-activated killer cells can be superior to intravenous application
U Keilholz, P Schlag, W Tilgen, et al.
Blood
|
March 1, 1990
Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia
A D Ho, M Grossman, L Trümper, et al.
Blood
|
November 1, 1989
Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia
M Körbling, W Hunstein, T M Fliedner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1990
Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site
M Körbling, R Holle, R Haas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 1, 1997
Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer
R Haas, H Schmid, U Hahn, et al.
Cancer
|
October 1, 1989
Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphoma
A D Ho, F del Valle, H Rückle, et al.
Seminars in Oncology
|
December 1, 1993
Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia
R Haas, A D Ho, F Del Valle, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 190) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 190 results.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1989
Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomas
B Wiedenmann, P Reichardt, U Räth, et al.
Cancer
|
July 15, 1993
Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials
U Keilholz, C Scheibenbogen, W Tilgen, et al.
Leukemia Research
|
January 1, 1990
Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsiveness
C Weiss, A D Ho, E Hiller, et al.
Cancer
|
April 15, 1992
Regional administration of lymphokine-activated killer cells can be superior to intravenous application
U Keilholz, P Schlag, W Tilgen, et al.
Blood
|
March 1, 1990
Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia
A D Ho, M Grossman, L Trümper, et al.
Blood
|
November 1, 1989
Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia
M Körbling, W Hunstein, T M Fliedner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1990
Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site
M Körbling, R Holle, R Haas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 1, 1997
Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer
R Haas, H Schmid, U Hahn, et al.
Cancer
|
October 1, 1989
Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphoma
A D Ho, F del Valle, H Rückle, et al.
Seminars in Oncology
|
December 1, 1993
Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia
R Haas, A D Ho, F Del Valle, et al.
Page
of 19